Abstract
Introduction of water-solubilizing groups on the 5-phenyl ring of a 2-aminopyrazine series led to the identification of highly potent compounds against the blood life-cycle stage of the human malaria parasite Plasmodium falciparum. Several compounds displayed high in vivo efficacy in two different mouse models for malaria, P. berghei-infected mice and P. falciparum-infected NOD-scid IL-2Rγnull mice. One of the frontrunners, compound 3, was identified to also have good pharmacokinetics and additionally very potent activity against the liver and gametocyte parasite life-cycle stages.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antimalarials / chemistry
-
Antimalarials / metabolism
-
Antimalarials / pharmacology*
-
Disease Models, Animal
-
Dose-Response Relationship, Drug
-
Ether-A-Go-Go Potassium Channels / antagonists & inhibitors
-
Ether-A-Go-Go Potassium Channels / metabolism
-
Hep G2 Cells
-
Humans
-
Life Cycle Stages / drug effects*
-
Malaria / drug therapy*
-
Mice
-
Mice, SCID
-
Microsomes, Liver / chemistry
-
Microsomes, Liver / metabolism
-
Molecular Structure
-
Parasitic Diseases, Animal / drug therapy*
-
Parasitic Diseases, Animal / parasitology
-
Parasitic Sensitivity Tests
-
Plasmodium berghei / drug effects*
-
Plasmodium berghei / growth & development
-
Plasmodium falciparum / drug effects*
-
Plasmodium falciparum / growth & development
-
Pyrazines / chemistry
-
Pyrazines / metabolism
-
Pyrazines / pharmacology*
-
Solubility
-
Structure-Activity Relationship
-
Water / chemistry
Substances
-
Antimalarials
-
Ether-A-Go-Go Potassium Channels
-
Pyrazines
-
Water
-
2-aminopyrazine